Publications by authors named "Ray E Gleason"

Claim this Profile
D
Does calcium channel blockade have a role in prevention of expression of sepsis in renal transplant recipients?
John A D'Elia, Ray E Gleason, Anthony P Monaco, Larry A Weinrauch

Int J Nephrol Renovasc Dis· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular-renal complications and the possible role of plasminogen activator inhibitor: a review.
John A D'Elia, George Bayliss, Ray E Gleason, Larry A Weinrauch

Clin Kidney J· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do biologic markers predict cardiovascular end points in diabetic end-stage renal disease? A prospective longitudinal study.
George P Bayliss, Larry A Weinrauch, Ray E Gleason, Annette T Lee, John A D'Elia

Clin Kidney J· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetic microvascular complications: possible targets for improved macrovascular outcomes.
John A D'Elia, George Bayliss, Bijan Roshan, Manish Maski, Ray E Gleason

Int J Nephrol Renovasc Dis· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulsatile intermittent intravenous insulin therapy for attenuation of retinopathy and nephropathy in type 1 diabetes mellitus.
Larry A Weinrauch, Jennifer Sun, Ray E Gleason, Guenther H Boden, R H Creech

Metabolism· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of an abbreviated diabetes impact management scale to assess change in subjective disability during a trial of pulsatile insulin delivery demonstrates benefit.
Larry A Weinrauch, George Bayliss, Ray E Gleason, Annette T Lee, John A D'Elia

Metabolism· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study to assess utility of changes in elements of the Diabetes Impact Management Scale in evaluating diabetic patients for progressive nephropathy.
Larry A Weinrauch, George Bayliss, Ray E Gleason, Annette T Lee, John A D'Elia

Metabolism· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study to test the effect of pulsatile insulin infusion on cardiovascular mechanisms that might contribute to attenuation of renal compromise in type 1 diabetes mellitus patients with proteinuria.
Larry A Weinrauch, Andrew J Burger, Franz Aepfelbacher, Annette T Lee, Ray E Gleason

Metabolism· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regression of left ventricular hypertrophy in diabetic nephropathy: loss of parasympathetic function predicts response to treatment.
Larry A Weinrauch, Andrew J Berger, Doron Aronson, Ray E Gleason, Annette T Lee

J Clin Hypertens (Greenwich)· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for thromboembolic events in renal failure.
John A D'Elia, Larry A Weinrauch, Ray E Gleason, Izabela Lipinska, Boguslaw Lipinski

Int J Cardiol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Left ventricular mass reduction in type 1 diabetic patients with nephropathy.
Larry A Weinrauch, Andrew Burger, Ray E Gleason, Annette T Lee, John A D'Elia

J Clin Hypertens (Greenwich)· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis